What is Patient Experience Data Why Do We Collect It

At Carevive, we are dedicated to harnessing the transformative potential of patient experience data and its value across the healthcare ecosystem. Patient experience data offers a holistic, longitudinal view of cancer patients throughout their treatment journey, encompassing vital aspects like symptoms, quality of life, physical function, and other critical outcomes.

We firmly believe that patient experience data is the future of healthcare delivery, paving the way for significant improvements in cancer care and patient outcomes. From drug development to reducing the cost of care, every stakeholder benefits from the insights gleaned from this data. Clinicians can streamline workflows, enabling access to patient-reported outcomes and automated patient management, including remote monitoring.

Moreover, comprehensive patient experience data allows for improved transparency across the care team, eliminating communication barriers and streamlining symptom management and triage processes. This empowers healthcare professionals to focus efficiently on the patients who need them the most, precisely when they need them.

We are committed to keeping you updated and transparent about how Carevive perceives and defines the additional value that patient experience data brings to the oncology market. Join us on this transformative journey as we explore the full potential of this data, making a positive impact on cancer care for patients and providers alike. Together, let’s shape a future of personalized and efficient cancer care.

Recent Episodes

In this episode of Care Anywhere: The Global Health Workforce Podcast, host Lea Sims welcomes Syl Trepanier, DNP, RN, Chief Nursing Officer for Providence Health and member of the TruMerit Board of Trustees. With responsibility for representing more than 36,000 nurses across a multi-state health system, Syl shares his personal journey from caregiving as…

The accelerator model is undergoing a transformation, and at the center of this change is HealthTech Arkansas, a powerful program that’s redefining the traditional approach by guaranteeing clinical pilots for healthcare startups. As the healthcare system faces a mounting burden from chronic disease (cardiovascular-related costs alone are projected to reach a staggering $1.8 trillion…

Michael Rothman explores the complexities of sepsis identification and management, highlighting the challenges posed by varying definitions and clinical pathways. He discusses the ineffectiveness of current sepsis screening protocols, which often yield high false-positive rates and fail to reduce mortality meaningfully. The episode concludes by questioning the focus on sepsis-specific initiatives and suggesting that more…